Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Molecular Diagnostics of Genetic Myopathy in Indian Subcontinent

ABSTRACT: Molecular Diagnostics of Genetic Myopathy in Indian Subcontinent using Exome sequencing

PROVIDER: PRJEB40370 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Genetic Susceptibility to Statin-Induced Myopathy

Project description:Genetic Susceptibility to Statin-Induced Myopathy

| PRJNA381255 | ENA

Gene expression-based, molecular pathomechanism prediction for GNE myopathy III

Project description:Molecular impacts in the pathogenesis of GNE myopathy in model mouse muscles were well described through expression profiling of a total of 34000 genes

2017-07-01 | GSE95150 | GEO

Gene expression-based, molecular pathomechanism prediction for GNE myopathy II

Project description:Molecular impacts of 1% N-acetylcysteine treatment on GNE myopathy model mice were well described through expression profiling of a total of 34000 genes

2017-07-01 | GSE95149 | GEO

Gene expression-based, molecular pathomechanism prediction for GNE myopathy I

Project description:Molecular impacts of 0.1% N-acetylcysteine treatment on GNE myopathy model mice were well described through expression profiling of a total of 34000 genes

2017-07-01 | GSE95148 | GEO

Molecular Diagnostics in Sepsis: from Bedside to Bench

Project description:Molecular Diagnostics in Sepsis: from Bedside to Bench

| PRJNA96877 | ENA

Gene expression-based, molecular pathomechanism prediction for GNE myopathy

Project description:Gene expression-based, molecular pathomechanism prediction for GNE myopathy

| PRJNA376192 | ENA

Cellular and molecular alterations to muscles and neuromuscular synapses in Megf10-related myopathy

Project description:Loss-of-function mutations in MEGF10 lead to a rare and understudied neuromuscular disorder known as MEGF10-related myopathy. There are no treatments for the progressive respiratory distress, motor impairment, and structural abnormalities in muscles caused by the loss of MEGF10 function. In this study, we asked whether mice lacking MEGF10 (MEGF10 KO) could be used as a model to generate preclinical insights to treat MEGF10-related myopathy. We deployed cellular and molecular assays to examine juvenile, young adult, and middle-aged Megf10 constitutive knockout (KO) mice. We found fewer muscle fibers in developing and adult Megf10 KO mice, supporting published studies that MEGF10 regulates myogenesis by affecting satellite cell differentiation. Interestingly, muscle fibers do not exhibit morphological hallmarks of atrophy in either young adult or middle-aged Megf10 KO mice. We next examined the neuromuscular junction (NMJ), in which MEGF10 has been shown to concentrate postnatally, using light and electron microscopy. We found early and progressive degenerative features at the NMJs of Megf10 KO mice. These include increased postsynaptic fragmentation, axon terminals failing to completely appose the postsynaptic region and perisynaptic Schwann cells intruding into the NMJ synaptic cleft. These findings strongly suggest that the NMJ is a site of postnatal pathology in MEGF10-related myopathy. We next sought to identify molecular mechanisms altered in muscles lacking Megf10 using RNA-seq. We discovered genes and pathways associated with myogenesis, skeletal muscle health, and NMJ stability dysregulated in Megf10 KO mice compared to wild-type mice. Altogether, these data support using MEGF10 KO mice to discover and test potential treatments for MEGF10-related myopathy.

2024-02-20 | GSE256199 | GEO

Statin-induced Myopathy

Project description:We performed a genome-wide association study in pooled DNA samples from patients with severe statin myopathy and persistent symptoms post-therapy versus pooled DNAs from an age-adjusted statin-tolerant group. Affymetrix 100K SNP arrays were used according to the manufacturers instructions with two pools of 19 and 20 statin myopathy patients and two pools of 20 statin-tolerant controls.

2010-07-09 | E-GEOD-17574 | biostudies-arrayexpress

Statin-induced Myopathy

2010-07-09 | GSE17574 | GEO

Nemaline myopathy mouse model

Project description:The aim of this study was to investigate the molecular mechanisms implicated in this mouse model of nemaline myopathy, and to further compare the molecular disease response in different skeletal muscles. For this purpose, snap frozen skeletla muscle specimens from wild type and transgenic for alpha tropomyosin slow mice were studied. Five different muscle types were used (diaphragm, plantaris, extensor digitorum longus, tibialis anterior, gastrocnemus). Mice were sacrificed between 7 and 10 months. RNA pools from 3-5 animals were created and each pool was hybridized to a U74Av2 Affymetrix GeneChip. Datasets from 36 GeneChips were included in this study. Keywords: disease mouse model analysis

2006-07-21 | GSE3384 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data